LAR4B_HUMAN - dbPTM
LAR4B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LAR4B_HUMAN
UniProt AC Q92615
Protein Name La-related protein 4B
Gene Name LARP4B
Organism Homo sapiens (Human).
Sequence Length 738
Subcellular Localization Cytoplasm, cytosol . Localized in cytoplasmic mRNP granules containing untranslated mRNAs in response to arsenite treatment.
Protein Description Stimulates mRNA translation..
Protein Sequence MTSDQDAKVVAEPQTQRVQEGKDSAHLMNGPISQTTSQTSSIPPLSQVPATKVSELNPNAEVWGAPVLHLEASSAADGVSAAWEEVAGHHADRGPQGSDANGDGDQGHENAALPDPQESDPADMNALALGPSEYDSLPENSETGGNESQPDSQEDPREVLKKTLEFCLSRENLASDMYLISQMDSDQYVPITTVANLDHIKKLSTDVDLIVEVLRSLPLVQVDEKGEKVRPNQNRCIVILREISESTPVEEVEALFKGDNLPKFINCEFAYNDNWFITFETEADAQQAYKYLREEVKTFQGKPIKARIKAKAIAINTFLPKNGFRPLDVSLYAQQRYATSFYFPPMYSPQQQFPLYSLITPQTWSATHSYLDPPLVTPFPNTGFINGFTSPAFKPAASPLTSLRQYPPRSRNPSKSHLRHAIPSAERGPGLLESPSIFNFTADRLINGVRSPQTRQAGQTRTRIQNPSAYAKREAGPGRVEPGSLESSPGLGRGRKNSFGYRKKREEKFTSSQTQSPTPPKPPSPSFELGLSSFPPLPGAAGNLKTEDLFENRLSSLIIGPSKERTLSADASVNTLPVVVSREPSVPASCAVSATYERSPSPAHLPDDPKVAEKQRETHSVDRLPSALTATACKSVQVNGAATELRKPSYAEICQRTSKEPPSSPLQPQKEQKPNTVGCGKEEKKLAEPAERYREPPALKSTPGAPRDQRRPAGGRPSPSAMGKRLSREQSTPPKSPQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MTSDQDAK
-------CCCHHHCC
7.9522814378
2Phosphorylation------MTSDQDAKV
------CCCHHHCCE
40.8023312004
3Phosphorylation-----MTSDQDAKVV
-----CCCHHHCCEE
31.7923312004
15PhosphorylationKVVAEPQTQRVQEGK
CEEECCCCHHHHCCC
29.1123312004
134PhosphorylationLALGPSEYDSLPENS
HHCCHHHHHCCCCCC
18.37-
135UbiquitinationALGPSEYDSLPENSE
HCCHHHHHCCCCCCC
39.3821890473
136PhosphorylationLGPSEYDSLPENSET
CCHHHHHCCCCCCCC
44.94-
145UbiquitinationPENSETGGNESQPDS
CCCCCCCCCCCCCCC
42.0021890473
154UbiquitinationESQPDSQEDPREVLK
CCCCCCCCCHHHHHH
74.1421890473
162UbiquitinationDPREVLKKTLEFCLS
CHHHHHHHHHHHHHC
54.93-
164UbiquitinationREVLKKTLEFCLSRE
HHHHHHHHHHHHCCC
6.9721890473
167GlutathionylationLKKTLEFCLSRENLA
HHHHHHHHHCCCCCC
2.1722555962
169PhosphorylationKTLEFCLSRENLASD
HHHHHHHCCCCCCCC
38.4427499020
188PhosphorylationSQMDSDQYVPITTVA
ECCCCCCCCCEEEEE
17.1227642862
188UbiquitinationSQMDSDQYVPITTVA
ECCCCCCCCCEEEEE
17.1221890473
198UbiquitinationITTVANLDHIKKLST
EEEEECHHHHHHHCC
41.0721890473
201UbiquitinationVANLDHIKKLSTDVD
EECHHHHHHHCCCHH
44.2221906983
202UbiquitinationANLDHIKKLSTDVDL
ECHHHHHHHCCCHHH
47.25-
225UbiquitinationPLVQVDEKGEKVRPN
CCEEECCCCCCCCCC
68.8333845483
228UbiquitinationQVDEKGEKVRPNQNR
EECCCCCCCCCCCCE
52.8129967540
236GlutathionylationVRPNQNRCIVILREI
CCCCCCEEEEEEEEH
3.7022555962
244PhosphorylationIVILREISESTPVEE
EEEEEEHHCCCCHHH
22.2728464451
246PhosphorylationILREISESTPVEEVE
EEEEHHCCCCHHHHH
31.0830087585
247PhosphorylationLREISESTPVEEVEA
EEEHHCCCCHHHHHH
27.5720873877
257UbiquitinationEEVEALFKGDNLPKF
HHHHHHHCCCCCCCE
67.2321906983
296UbiquitinationYKYLREEVKTFQGKP
HHHHHHHHHHHCCCC
6.4027667366
297UbiquitinationKYLREEVKTFQGKPI
HHHHHHHHHHCCCCC
47.0729967540
302UbiquitinationEVKTFQGKPIKARIK
HHHHHCCCCCCHHHH
32.5529967540
305UbiquitinationTFQGKPIKARIKAKA
HHCCCCCCHHHHHEE
39.8929967540
311UbiquitinationIKARIKAKAIAINTF
CCHHHHHEEEEEECC
35.0121890473
311UbiquitinationIKARIKAKAIAINTF
CCHHHHHEEEEEECC
35.0121906983
315UbiquitinationIKAKAIAINTFLPKN
HHHEEEEEECCCCCC
4.0027667366
320UbiquitinationIAINTFLPKNGFRPL
EEEECCCCCCCCCCC
24.7127667366
321UbiquitinationAINTFLPKNGFRPLD
EEECCCCCCCCCCCC
72.3721890473
321UbiquitinationAINTFLPKNGFRPLD
EEECCCCCCCCCCCC
72.3727667366
330PhosphorylationGFRPLDVSLYAQQRY
CCCCCCCHHHCCHHH
18.4829978859
332PhosphorylationRPLDVSLYAQQRYAT
CCCCCHHHCCHHHCC
8.5429978859
339UbiquitinationYAQQRYATSFYFPPM
HCCHHHCCCCCCCCC
15.5027667366
349UbiquitinationYFPPMYSPQQQFPLY
CCCCCCCCCCCCCEE
20.6427667366
373UbiquitinationATHSYLDPPLVTPFP
CCCCCCCCCCCCCCC
22.8727667366
389PhosphorylationTGFINGFTSPAFKPA
CCCCCCCCCCCCCCC
34.8920068231
390PhosphorylationGFINGFTSPAFKPAA
CCCCCCCCCCCCCCC
16.3926074081
398PhosphorylationPAFKPAASPLTSLRQ
CCCCCCCCCCCCHHH
23.6529255136
401PhosphorylationKPAASPLTSLRQYPP
CCCCCCCCCHHHCCC
29.1520068231
402PhosphorylationPAASPLTSLRQYPPR
CCCCCCCCHHHCCCC
29.2729978859
404MethylationASPLTSLRQYPPRSR
CCCCCCHHHCCCCCC
33.4824129315
414PhosphorylationPPRSRNPSKSHLRHA
CCCCCCCCHHHHHHH
50.7924719451
415UbiquitinationPRSRNPSKSHLRHAI
CCCCCCCHHHHHHHC
43.05-
419DimethylationNPSKSHLRHAIPSAE
CCCHHHHHHHCCCCC
16.27-
419MethylationNPSKSHLRHAIPSAE
CCCHHHHHHHCCCCC
16.2724129315
424PhosphorylationHLRHAIPSAERGPGL
HHHHHCCCCCCCCCC
36.3322617229
427MethylationHAIPSAERGPGLLES
HHCCCCCCCCCCCCC
57.21115481823
434PhosphorylationRGPGLLESPSIFNFT
CCCCCCCCCCCEEEC
24.7429255136
436PhosphorylationPGLLESPSIFNFTAD
CCCCCCCCCEEECHH
49.4429255136
441PhosphorylationSPSIFNFTADRLING
CCCCEEECHHHHHCC
28.8429255136
444MethylationIFNFTADRLINGVRS
CEEECHHHHHCCCCC
34.7080702951
451PhosphorylationRLINGVRSPQTRQAG
HHHCCCCCCCCCCCC
20.9625159151
454PhosphorylationNGVRSPQTRQAGQTR
CCCCCCCCCCCCCCC
28.2923403867
463MethylationQAGQTRTRIQNPSAY
CCCCCCCCCCCHHHH
25.79115481839
468PhosphorylationRTRIQNPSAYAKREA
CCCCCCHHHHHCCCC
41.2728555341
470PhosphorylationRIQNPSAYAKREAGP
CCCCHHHHHCCCCCC
19.5925839225
472MethylationQNPSAYAKREAGPGR
CCHHHHHCCCCCCCC
37.79115972353
472UbiquitinationQNPSAYAKREAGPGR
CCHHHHHCCCCCCCC
37.7927667366
484PhosphorylationPGRVEPGSLESSPGL
CCCCCCCCCCCCCCC
39.4122777824
487PhosphorylationVEPGSLESSPGLGRG
CCCCCCCCCCCCCCC
47.3122777824
488PhosphorylationEPGSLESSPGLGRGR
CCCCCCCCCCCCCCC
17.3821815630
493DimethylationESSPGLGRGRKNSFG
CCCCCCCCCCCCCCC
46.95-
493MethylationESSPGLGRGRKNSFG
CCCCCCCCCCCCCCC
46.9516188947
495MethylationSPGLGRGRKNSFGYR
CCCCCCCCCCCCCCC
33.3530987767
496UbiquitinationPGLGRGRKNSFGYRK
CCCCCCCCCCCCCCH
60.8227667366
498PhosphorylationLGRGRKNSFGYRKKR
CCCCCCCCCCCCHHC
24.0822167270
501PhosphorylationGRKNSFGYRKKREEK
CCCCCCCCCHHCHHH
19.7628152594
510PhosphorylationKKREEKFTSSQTQSP
HHCHHHCCCCCCCCC
38.2430278072
511PhosphorylationKREEKFTSSQTQSPT
HCHHHCCCCCCCCCC
24.4730278072
512PhosphorylationREEKFTSSQTQSPTP
CHHHCCCCCCCCCCC
33.9030278072
514PhosphorylationEKFTSSQTQSPTPPK
HHCCCCCCCCCCCCC
32.7230278072
516PhosphorylationFTSSQTQSPTPPKPP
CCCCCCCCCCCCCCC
33.8430278072
518PhosphorylationSSQTQSPTPPKPPSP
CCCCCCCCCCCCCCC
58.4325159151
524PhosphorylationPTPPKPPSPSFELGL
CCCCCCCCCCEECCC
41.5225159151
526PhosphorylationPPKPPSPSFELGLSS
CCCCCCCCEECCCCC
35.3730278072
532PhosphorylationPSFELGLSSFPPLPG
CCEECCCCCCCCCCC
28.3030278072
533PhosphorylationSFELGLSSFPPLPGA
CEECCCCCCCCCCCC
46.9824888630
546PhosphorylationGAAGNLKTEDLFENR
CCCCCCCHHHHHHHC
37.5928122231
553MethylationTEDLFENRLSSLIIG
HHHHHHHCCHHCEEC
28.84115481831
555PhosphorylationDLFENRLSSLIIGPS
HHHHHCCHHCEECCC
21.6220068231
556PhosphorylationLFENRLSSLIIGPSK
HHHHCCHHCEECCCC
28.3423401153
562PhosphorylationSSLIIGPSKERTLSA
HHCEECCCCCCEECC
41.7720068231
563UbiquitinationSLIIGPSKERTLSAD
HCEECCCCCCEECCC
55.1133845483
566PhosphorylationIGPSKERTLSADASV
ECCCCCCEECCCCCC
26.5929255136
568PhosphorylationPSKERTLSADASVNT
CCCCCEECCCCCCCC
24.4029255136
572PhosphorylationRTLSADASVNTLPVV
CEECCCCCCCCCCEE
19.2228102081
575PhosphorylationSADASVNTLPVVVSR
CCCCCCCCCCEEEEC
30.2230576142
581O-linked_GlycosylationNTLPVVVSREPSVPA
CCCCEEEECCCCCCC
21.2230059200
581PhosphorylationNTLPVVVSREPSVPA
CCCCEEEECCCCCCC
21.2230576142
585PhosphorylationVVVSREPSVPASCAV
EEEECCCCCCCCEEE
35.6627696853
589O-linked_GlycosylationREPSVPASCAVSATY
CCCCCCCCEEEEEEE
9.1330059200
589PhosphorylationREPSVPASCAVSATY
CCCCCCCCEEEEEEE
9.1327696853
593O-linked_GlycosylationVPASCAVSATYERSP
CCCCEEEEEEEECCC
9.0730059200
593PhosphorylationVPASCAVSATYERSP
CCCCEEEEEEEECCC
9.0725159151
595PhosphorylationASCAVSATYERSPSP
CCEEEEEEEECCCCC
20.5725159151
596PhosphorylationSCAVSATYERSPSPA
CEEEEEEEECCCCCC
14.7327696853
599PhosphorylationVSATYERSPSPAHLP
EEEEEECCCCCCCCC
20.1429255136
601PhosphorylationATYERSPSPAHLPDD
EEEECCCCCCCCCCC
35.6529255136
618PhosphorylationVAEKQRETHSVDRLP
HHHHHHHHCCCCCCC
22.9530108239
620PhosphorylationEKQRETHSVDRLPSA
HHHHHHCCCCCCCHH
32.8825849741
623MethylationRETHSVDRLPSALTA
HHHCCCCCCCHHHHH
46.47115481815
626PhosphorylationHSVDRLPSALTATAC
CCCCCCCHHHHHHHC
40.2730108239
629PhosphorylationDRLPSALTATACKSV
CCCCHHHHHHHCCEE
22.9823312004
631PhosphorylationLPSALTATACKSVQV
CCHHHHHHHCCEEEE
27.6130387612
635PhosphorylationLTATACKSVQVNGAA
HHHHHCCEEEECCCH
20.0516674116
643PhosphorylationVQVNGAATELRKPSY
EEECCCHHCCCCCCH
34.7120068231
647UbiquitinationGAATELRKPSYAEIC
CCHHCCCCCCHHHHH
51.4429967540
649PhosphorylationATELRKPSYAEICQR
HHCCCCCCHHHHHHH
39.7626657352
650PhosphorylationTELRKPSYAEICQRT
HCCCCCCHHHHHHHC
19.4428796482
654GlutathionylationKPSYAEICQRTSKEP
CCCHHHHHHHCCCCC
1.3622555962
657PhosphorylationYAEICQRTSKEPPSS
HHHHHHHCCCCCCCC
20.4823403867
658PhosphorylationAEICQRTSKEPPSSP
HHHHHHCCCCCCCCC
36.8923403867
663PhosphorylationRTSKEPPSSPLQPQK
HCCCCCCCCCCCCCC
56.1329255136
664PhosphorylationTSKEPPSSPLQPQKE
CCCCCCCCCCCCCCC
35.0929255136
676PhosphorylationQKEQKPNTVGCGKEE
CCCCCCCCCCCCHHH
27.1419690332
693PhosphorylationLAEPAERYREPPALK
HHCHHHHHCCCCHHH
15.7225159151
701PhosphorylationREPPALKSTPGAPRD
CCCCHHHCCCCCCCC
40.4629396449
702PhosphorylationEPPALKSTPGAPRDQ
CCCHHHCCCCCCCCC
24.9328985074
718PhosphorylationRPAGGRPSPSAMGKR
CCCCCCCCHHHHHHH
30.0829255136
720PhosphorylationAGGRPSPSAMGKRLS
CCCCCCHHHHHHHHH
34.9130266825
724AcetylationPSPSAMGKRLSREQS
CCHHHHHHHHHCCCC
36.7619608861
727PhosphorylationSAMGKRLSREQSTPP
HHHHHHHHCCCCCCC
37.4921712546
731PhosphorylationKRLSREQSTPPKSPQ
HHHHCCCCCCCCCCC
37.8223401153
732PhosphorylationRLSREQSTPPKSPQ-
HHHCCCCCCCCCCC-
43.2225159151
736PhosphorylationEQSTPPKSPQ-----
CCCCCCCCCC-----
34.0229255136
753Phosphorylation----------------------
----------------------
32142685
767Phosphorylation------------------------------------
------------------------------------
33259812
811Ubiquitination--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
21890473
821Ubiquitination------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------
21890473
972Ubiquitination-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27667366
996Ubiquitination-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
27667366

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LAR4B_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LAR4B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LAR4B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of LAR4B_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LAR4B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-724, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424; THR-518 ANDSER-524, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663; SER-664; SER-727;THR-732 AND SER-736, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424 AND SER-434;SER-451; SER-516; SER-524; SER-727; THR-732 AND SER-736, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434 AND SER-568, ANDMASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434 AND THR-566, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601 AND SER-718, ANDMASS SPECTROMETRY.

TOP